Drug-Induced Hepatotoxicity
The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
Abstract
Drug-induced hepatic injury accounts for more than 50 percent of cases of acute liver failure in the United States. More than 75 percent of idiosyncratic drug reactions result in liver transplantation or death. This review discusses the pathogenesis of drug-induced liver injury, common adverse drug reactions involving the liver, and the drug-approval process. Monitoring for and recognition of drug-induced hepatotoxicity may prevent some cases of acute hepatic failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that many variables, such as genetic variability, race, sex, age, metabolic capacity, drug-drug interactions, and preexisting diseases, contribute to individual susceptibility and toxicity of idiosyncratic drugs (Lee, 2003).”
From Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent (2012) · cites this paper as Lee, 2003
In the citing paper
“Under these limited conditions, two-dimensional (2D) monolayered cells exhibit altered biological features, including morphology, function, hepatic polarity, and genotype expression (Lasser et al., 2002;Lee, 2003;Ma et al., 2023).”
From Fast formation and maturation enhancement of human liver organoids using a liver-organoid-on-a-chip (2024) · cites this paper as Lee, 2003
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Self-citationEarly indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE
Mitchell, J. R., Jollow, D. J., Potter, W. Z., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29666-5 · Cited by 1,737
Role of Quinones in Toxicology
Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology · doi:10.1021/tx9902082 · Cited by 1,703
Common and Uncommon Cytochrome P450 Reactions Related to Metabolism and Chemical Toxicity
Guengerich, F. P. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002583 · Cited by 1,655
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
Jaeschke, H. (2002) · Toxicological Sciences · doi:10.1093/toxsci/65.2.166 · Cited by 1,304
McDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G., Wolford, J. L., Banaji, M., Hardin, B. J., Shulman, H. M., & Clift, R. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-4-199302150-00003 · Cited by 1,202
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102
Research works printed but not linked: 9
- Yun CH, 1993, Drug Metab Dispos, 21, 403
- Chitturi S, 2001, Semin Gastrointest Dis, 12, 113
- Wang K, 1999, Zhonghua Yi Xue Za Zhi (Taipei), 62, 369
- George J, 1995, Hepatology, 21, 120
- Meadows M, 2001, FDA Consum, 35, 8
- Piliero PJ, 2001, AIDS Read, 11, 379
- 10.1111/j.1572-0241.1999.01091.x · doi:10.1111/j.1572-0241.1999.01091.x · Paper page
- Fernandes NF, 2000, Am J Gastroenterol, 95, 532, 10.1111/j.1572-0241.2000.t01-1-01780.x · doi:10.1111/j.1572-0241.2000.t01-1-01780.x · Paper page
- Graham DJ, 2002, Hepatology, 36, 168A
Cited by
Liver enzyme alteration: a guide for clinicians
Giannini, E. G. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040752 · Cited by 2,016
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114147 · Cited by 1,920
Drug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Navarro, V. J., & Senior, J. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052270 · Cited by 811
AASLD position paper: The management of acute liver failure†
Polson, J., & Lee, W. M. (2005) · Hepatology · doi:10.1002/hep.20703 · Cited by 974
Self-citationAndrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review
Tostmann, A., Boeree, M. J., Aarnoutse, R. E., De Lange, W. C. M., Van Der Ven, A. J. A. M., & Dekhuijzen, R. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05207.x · Cited by 781
Non-alcoholic fatty liver disease: An expanded review
Benedict, M., & Zhang, X. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i16.715 · Cited by 751
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
Self-citationNrf2, the Master Regulator of Anti-Oxidative Responses
Vomund, S., Schäfer, A., Parnham, M., Brüne, B., & Von Knethen, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122772 · Cited by 752
Hewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
Ibuprofen: pharmacology, efficacy and safety
Rainsford, K. D. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-0016-x · Cited by 667
O’Brien, P. J., Irwin, W., Diaz, D., Howard-Cofield, E., Krejsa, C. M., Slaughter, M. R., Gao, B., Kaludercic, N., Angeline, A., Bernardi, P., et al. (2006) · Archives of Toxicology · doi:10.1007/s00204-006-0091-3 · Cited by 609
Lee, W. M., Stravitz, T. R., & Larson, A. M. (2012) · Hepatology · doi:10.1002/hep.25551 · Cited by 550
Self-citationCellular Imaging Predictions of Clinical Drug-Induced Liver Injury
Xu, J. J., Henstock, P. V., Dunn, M. C., Smith, A. R., Chabot, J. R., & de Graaf, D. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn109 · Cited by 492
Zigmond, E., Samia-Grinberg, S., Pasmanik-Chor, M., Brazowski, E., Shibolet, O., Halpern, Z., & Varol, C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400574 · Cited by 480
Liver transplantation for acute liver failure from drug induced liver injury in the United States
Russo, M. W., Galanko, J. A., Shrestha, R., Fried, M. W., & Watkins, P. (2004) · Liver Transplantation · doi:10.1002/lt.20204 · Cited by 393
Nolan, C. M., Goldberg, S. V., & Buskin, S. E. (1999) · JAMA · doi:10.1001/jama.281.11.1014 · Cited by 368
THE ROLE OF METABOLIC ACTIVATION IN DRUG-INDUCED HEPATOTOXICITY
Park, B. K., Kitteringham, N. R., Maggs, J. L., Pirmohamed, M., & Williams, D. P. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100058 · Cited by 453
Hepatotoxicity of Chemotherapy
King, P. D., & Perry, M. C. (2001) · The Oncologist · doi:10.1634/theoncologist.6-2-162 · Cited by 454
Huang, Y.-S., Chern, H.-D., Su, W.-J., Wu, J.-C., Lai, S.-L., Yang, S.-Y., Chang, F.-Y., & Lee, S.-D. (2002) · Hepatology · doi:10.1053/jhep.2002.32102 · Cited by 432
Shahidi, N. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80114-4 · Cited by 429
Cytochrome P450 2E1 Genotype and the Susceptibility to Antituberculosis Drug–Induced Hepatitis
Huang, Y.-S., Chern, H.-D., Su, W.-J., Wu, J.-C., Chang, S.-C., Chiang, C.-H., Chang, F.-Y., & Lee, S.-D. (2003) · Hepatology · doi:10.1053/jhep.2003.50144 · Cited by 426
Toxicogenomics and systems toxicology: aims and prospects
Waters, M. D., & Fostel, J. M. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1493 · Cited by 415
Acetaminophen Toxicity in an Urban County Hospital
Schiødt, F. V., Rochling, F. A., Casey, D. L., & Lee, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371602 · Cited by 422
Self-citationEzekowitz, M. D., Reilly, P. A., Nehmiz, G., Simmers, T. A., Nagarakanti, R., Parcham-Azad, K., Pedersen, K. E., Lionetti, D. A., Stangier, J., & Wallentin, L. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.034 · Cited by 419
Holt, M. P., Cheng, L., & Ju, C. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0308173 · Cited by 399
Padda, M. S., Sanchez, M., Akhtar, A. J., & Boyer, J. L. (2011) · Hepatology · doi:10.1002/hep.24229 · Cited by 387
Designing nanozymes for in vivo applications
Zhang, R., Jiang, B., Fan, K., Gao, L., & Yan, X. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00205-1 · Cited by 360
Swift*, B., Pfeifer*, N. D., & Brouwer, K. L. R. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903491881 · Cited by 365
Acetaminophen Hepatotoxicity and Acute Liver Failure
Chun, L. J., Tong, M. J., Busuttil, R. W., & Hiatt, J. R. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31818a3854 · Cited by 348
Morgan, R. E., Trauner, M., van Staden, C. J., Lee, P. H., Ramachandran, B., Eschenberg, M., Afshari, C. A., Qualls, C. W., Lightfoot-Dunn, R., & Hamadeh, H. K. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq269 · Cited by 325
Heavy Metal Mixture Exposure and Effects in Developing Nations: An Update
Anyanwu, B. O., Ezejiofor, A. N., Igweze, Z. N., & Orisakwe, O. E. (2018) · Toxics · doi:10.3390/toxics6040065 · Cited by 326
Mechanisms of drug-induced liver injury
Holt, M. P., & Ju, C. (2006) · The AAPS Journal · doi:10.1208/aapsj080106 · Cited by 328
Clinical Biochemistry of Hepatotoxicity
P Sharma, O. (2014) · Journal of Clinical Toxicology · doi:10.4172/2161-0495.s4-001 · Cited by 305
Acetaminophen-related Hepatotoxicity
Bunchorntavakul, C., & Reddy, K. R. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.07.005 · Cited by 322
Labbe, G., Pessayre, D., & Fromenty, B. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00608.x · Cited by 317
Idiosyncratic Drug Reactions: Current Understanding
Uetrecht, J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105150 · Cited by 304
The spread, treatment, and prevention of HIV-1: evolution of a global pandemic
Cohen, M. S., Hellmann, N., Levy, J. A., DeCock, K., & Lange, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34706 · Cited by 304
Bernal, P. N., Bouwmeester, M., Madrid‐Wolff, J., Falandt, M., Florczak, S., Rodriguez, N. G., Li, Y., Größbacher, G., Samsom, R., van Wolferen, M., et al. (2022) · Advanced Materials · doi:10.1002/adma.202110054 · Cited by 258
Pharmacogenomics: Challenges and Opportunities
Roden, D. M., Altman, R. B., Benowitz, N. L., Flockhart, D. A., Giacomini, K. M., Johnson, J. A., Krauss, R. M., McLeod, H. L., Ratain, M. J., Relling, M. V., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00007 · Cited by 282
Bajt, M. L. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh151 · Cited by 292
Measurement of Serum Acetaminophen–Protein Adducts in Patients With Acute Liver Failure
Davern, T. J., James, L. P., Hinson, J. A., Polson, J., Larson, A. M., Fontana, R. J., Lalani, E., Munoz, S., Shakil, A. O., & Lee, W. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.033 · Cited by 284
Self-citationDrug-induced liver injury: Summary of a single topic clinical research conference
Watkins, P. B., & Seeff, L. B. (2006) · Hepatology · doi:10.1002/hep.21095 · Cited by 279
Andersson, T. B., Kanebratt, K. P., & Kenna, J. G. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.685159 · Cited by 259
The hepatic stem cell niche: Identification by label-retaining cell assay
Kuwahara, R., Kofman, A. V., Landis, C. S., Swenson, S. E., Barendswaard, E., & Theise, N. D. (2008) · Hepatology · doi:10.1002/hep.22218 · Cited by 268
Review article: drug hepatotoxicity
CHANG, C. Y., & SCHIANO, T. D. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03307.x · Cited by 264
Drug-induced autoimmune-like hepatitis
Czaja, A. J. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1611-4 · Cited by 235
Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview
Singh, D., Cho, W. C., & Upadhyay, G. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2015.00363 · Cited by 252
A proof of concept study establishing Necator americanus in Crohn’s patients and reservoir donors
Croese, J., O’Neil, J., Masson, J., Cooke, S., Melrose, W., Pritchard, D., & Speare, R. (2006) · Gut · doi:10.1136/gut.2005.079129 · Cited by 216
Natural products in licorice for the therapy of liver diseases: Progress and future opportunities
Li, X., Sun, R., & Liu, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.025 · Cited by 256
Sturgill, M. G., & Lambert, G. H. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.8.1512 · Cited by 252
Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?
Bessone, F. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i45.5651 · Cited by 248
Acute Liver Failure Including Acetaminophen Overdose
Fontana, R. J. (2008) · Medical Clinics of North America · doi:10.1016/j.mcna.2008.03.005 · Cited by 249
Severe Hepatotoxicity Associated with Nevirapine Use in HIV‐Infected Subjects
Sanne, I., Mommeja‐Marin, H., Hinkle, J., Bartlett, J. A., Lederman, M. M., Maartens, G., Wakeford, C., Shaw, A., Quinn, J., Gish, R. G., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428093 · Cited by 242
First dose of potential new medicines to humans: how animals help
Greaves, P., Williams, A., & Eve, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1329 · Cited by 243
Zebrafish models for assessing developmental and reproductive toxicity
He, J.-H., Gao, J.-M., Huang, C.-J., & Li, C.-Q. (2014) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2014.01.006 · Cited by 233
The detoxification enzyme systems.
Liska, D. J. (1998) · PubMed · Cited by 237
PHARMACOGENETICS IN PEDIATRICS
Leeder, J. S., & Kearns, G. L. (1997) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70463-6 · Cited by 234
Rosenberg, P., Urwitz, H., Johannesson, A., Ros, A.-M., Lindholm, J., Kinnman, N., & Hultcrantz, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.024 · Cited by 185
Biomarkers of Hepatic Toxicity: An Overview
Thakur, S., Kumar, V., Das, R., Sharma, V., & Mehta, D. K. (2024) · Current Therapeutic Research · doi:10.1016/j.curtheres.2024.100737 · Cited by 175
Xu, J. J., Diaz, D., & O’Brien, P. J. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.09.011 · Cited by 224
Martin-Murphy, B. V., Holt, M. P., & Ju, C. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2009.11.016 · Cited by 226
Allergic Reactions to Drugs and Biologic Agents
deShazo, R. D. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550220101014 · Cited by 227
Design Strategy of Fluorescent Probes for Live Drug-Induced Acute Liver Injury Imaging
Cheng, D., Xu, W., Gong, X., Yuan, L., & Zhang, X.-B. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00646 · Cited by 220
Chitturi, S., & Farrell, G. C. (2000) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-000-0034-7 · Cited by 220
Pathophysiological Basis for Antioxidant Therapy in Chronic Liver Disease
Medina, J., & Moreno-Otero, R. (2005) · Drugs · doi:10.2165/00003495-200565170-00003 · Cited by 216
Hou, J.-T., Yu, K.-K., Sunwoo, K., Kim, W. Y., Koo, S., Wang, J., Ren, W. X., Wang, S., Yu, X.-Q., & Kim, J. S. (2020) · Chem · doi:10.1016/j.chempr.2019.12.005 · Cited by 208
Huang, Y.-S., Su, W.-J., Huang, Y.-H., Chen, C.-Y., Chang, F.-Y., Lin, H.-C., & Lee, S.-D. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.009 · Cited by 212
PPARs and the Cardiovascular System
Hamblin, M., Chang, L., Fan, Y., Zhang, J., & Chen, Y. E. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2280 · Cited by 207
Role of the Nrf2-ARE Pathway in Liver Diseases
Shin, S. M., Yang, J. H., & Ki, S. H. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/763257 · Cited by 205
Thiopurine-Induced Liver Injury in Patients With Inflammatory Bowel Disease: A Systematic Review
Gisbert, J. P., González-Lama, Y., & Maté, J. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01187.x · Cited by 202
Drug-Induced Liver Injury Associated with the Use of Nonnucleoside Reverse-Transcriptase Inhibitors
Dieterich, D. T., Robinson, P. A., Love, J., & Stern, J. O. (2004) · Clinical Infectious Diseases · doi:10.1086/381450 · Cited by 205
Analgesics in Patients with Hepatic Impairment: Pharmacology and Clinical Implications
Bosilkovska, M., Walder, B., Besson, M., Daali, Y., & Desmeules, J. (2012) · Drugs · doi:10.2165/11635500-000000000-00000 · Cited by 199
Ingawale, D. K., Mandlik, S. K., & Naik, S. R. (2014) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.08.015 · Cited by 202
Jossé, R., Aninat, C., Glaise, D., Dumont, J., Fessard, V., Morel, F., Poul, J.-M., Guguen-Guillouzo, C., & Guillouzo, A. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.019901 · Cited by 187
Drug-Induced Hepatotoxicity: 2005
Maddrey, W. C. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000155548.91524.6e · Cited by 201
Paulose‐Ram, R., Hirsch, R., Dillon, C., Losonczy, K., Cooper, M., & Ostchega, Y. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.755 · Cited by 198
Li, Y., Xie, X., Yang, X., Li, M., Jiao, X., Sun, Y., Wang, X., & Tang, B. (2017) · Chemical Science · doi:10.1039/c7sc00303j · Cited by 197
Curcumin and Liver Disease: from Chemistry to Medicine
Nabavi, S. F., Daglia, M., Moghaddam, A. H., Habtemariam, S., & Nabavi, S. M. (2014) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12047 · Cited by 192
Andrade, E. L., Bento, A. F., Cavalli, J., Oliveira, S. K., Schwanke, R. C., Siqueira, J. M., Freitas, C. S., Marcon, R., & Calixto, J. B. (2016) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20165646 · Cited by 184
Pharmacological actions of curcumin in liver diseases or damage
Rivera‐Espinoza, Y., & Muriel, P. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02086.x · Cited by 191
Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case Report
Al-Salman, J., Arjomand, H., Kemp, D. G., & Mittal, M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00006 · Cited by 196
Incidence of drug-induced liver injury in medical inpatients
Meier, Y., Cavallaro, M., Roos, M., Pauli-Magnus, C., Folkers, G., Meier, P. J., & Fattinger, K. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0888-z · Cited by 158
Reuben, A. (2004) · Hepatology · doi:10.1002/hep.20081 · Cited by 190
Firenzuoli, F., Gori, L., & di Sarsina, P. R. (2011) · Evidence-Based Complementary and Alternative Medicine · doi:10.1093/ecam/nen009 · Cited by 187
Clinical hepatotoxicity associated with antifungal agents
Kyriakidis, I., Tragiannidis, A., Munchen, S., & Groll, A. H. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1270264 · Cited by 187
Practical guidelines for diagnosis and early management of drug-induced liver injury
Tajiri, K., & Shimizu, Y. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6774 · Cited by 186
Li, D., Wang, S., Lei, Z., Sun, C., El-Toni, A. M., Alhoshan, M. S., Fan, Y., & Zhang, F. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00317 · Cited by 188
Optimization of the HepaRG cell model for drug metabolism and toxicity studies
Anthérieu, S., Chesné, C., Li, R., Guguen-Guillouzo, C., & Guillouzo, A. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.05.008 · Cited by 177
Effect of l -carnitine treatment for valproate-induced hepatotoxicity
Bohan, T. P., Helton, E., McDonald, I., König, S., Gazitt, S., Sugimoto, T., Scheffner, D., Cusmano, L., Li, S., & Koch, G. (2001) · Neurology · doi:10.1212/wnl.56.10.1405 · Cited by 184
Recognizing Drug-Induced Liver Injury: Current Problems, Possible Solutions
Lee, W. M., & Senior, J. R. (2005) · Toxicologic Pathology · doi:10.1080/01926230590522356 · Cited by 190
Self-citationPorceddu, M., Buron, N., Roussel, C., Labbe, G., Fromenty, B., & Borgne-Sanchez, A. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs197 · Cited by 181
Boussios, S., Pentheroudakis, G. E., Katsanos, K. H., & Pavlidis, N. A. (2012) · PubMed Central · Cited by 200
Hepatic Findings in Long-Term Clinical Trials of Ximelagatran
Lee, W. M., Larrey, D., Olsson, R., Lewis, J. H., Keisu, M., Auclert, L., & Sheth, S. (2005) · Drug Safety · doi:10.2165/00002018-200528040-00006 · Cited by 189
Self-citationAcetaminophen (APAP or N-Acetyl-p-Aminophenol) and Acute Liver Failure
Bunchorntavakul, C., & Reddy, K. R. (2018) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.01.007 · Cited by 179
Idiosyncratic drug-induced liver injury: an overview
Hussaini, S. H., & Farrington, E. A. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.6.673 · Cited by 183
The interplay between thyroid and liver: implications for clinical practice
Piantanida, E., Ippolito, S., Gallo, D., Masiello, E., Premoli, P., Cusini, C., Rosetti, S., Sabatino, J., Segato, S., Trimarchi, F., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01208-6 · Cited by 176
Black cohosh and other herbal remedies associated with acute hepatitis
Whiting, P. W., Clouston, A., & Kerlin, P. (2002) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2002.tb04886.x · Cited by 177
Metadata
- Authors
- Lee, W. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Lee, William M.
- ORCID
- Lee, William M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-07-31
- Volume
- 349
- Issue
- 5
- Pages
- 474-485
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3021092633
- Cited by
- 1,594
- References
- 180
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 33 · 2023: 41 · 2022: 44 · 2021: 44 · 2020: 53 · 2019: 69 · 2018: 69 · 2017: 75 · 2016: 84 · 2015: 74 · 2014: 95 · 2013: 88 · 2012: 88
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- drug-induced liver injury, acute liver failure, idiosyncratic drug reactions, adverse drug reactions, drug approval, hepatotoxicity monitoring, liver transplantation
- MeSH terms
- Troglitazone, Anti-Inflammatory Agents, Non-Steroidal, Benzophenones, Bromobenzenes, Chromans, Pharmaceutical Preparations, Humans, Hypoglycemic Agents, Liver, Liver Cirrhosis, Liver Diseases, Liver Function Tests, Pharmacology, Thiazoles, Drug Approval, Thiazolidinediones, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.